Medical Care

Global Endocrine Disruption Screening Market Research Report 2025

The global market for Endocrine Disruption Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The Endocrine Disruptor Screening is used to screen pesticides, chemicals, and other environmental contaminants for their potential to impact the androgen, estrogen, and thyroid hormone systems.
The Endocrine Disruptor Screening is used to screen pesticides, chemicals, and other environmental contaminants for their potential to impact the androgen, estrogen, and thyroid hormone systems.
This report aims to provide a comprehensive presentation of the global market for Endocrine Disruption Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Disruption Screening.
The Endocrine Disruption Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endocrine Disruption Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrine Disruption Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Bioarray
Xenometrix AG
Charles River Laboratories
Eurofins Scientific
Smithers
SGS SA
JRF Global
Mérieux NutriSciences
Alpha Analytical
Segment by Type
In Vitro Screening
In Vivo Screening
Segment by Application
Agricultural
Medical
Environmental
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocrine Disruption Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Disruption Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vitro Screening
1.2.3 In Vivo Screening
1.3 Market by Application
1.3.1 Global Endocrine Disruption Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Agricultural
1.3.3 Medical
1.3.4 Environmental
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Disruption Screening Market Perspective (2020-2031)
2.2 Global Endocrine Disruption Screening Growth Trends by Region
2.2.1 Global Endocrine Disruption Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Endocrine Disruption Screening Historic Market Size by Region (2020-2025)
2.2.3 Endocrine Disruption Screening Forecasted Market Size by Region (2026-2031)
2.3 Endocrine Disruption Screening Market Dynamics
2.3.1 Endocrine Disruption Screening Industry Trends
2.3.2 Endocrine Disruption Screening Market Drivers
2.3.3 Endocrine Disruption Screening Market Challenges
2.3.4 Endocrine Disruption Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Disruption Screening Players by Revenue
3.1.1 Global Top Endocrine Disruption Screening Players by Revenue (2020-2025)
3.1.2 Global Endocrine Disruption Screening Revenue Market Share by Players (2020-2025)
3.2 Global Endocrine Disruption Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Endocrine Disruption Screening Revenue
3.4 Global Endocrine Disruption Screening Market Concentration Ratio
3.4.1 Global Endocrine Disruption Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Disruption Screening Revenue in 2024
3.5 Global Key Players of Endocrine Disruption Screening Head office and Area Served
3.6 Global Key Players of Endocrine Disruption Screening, Product and Application
3.7 Global Key Players of Endocrine Disruption Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Disruption Screening Breakdown Data by Type
4.1 Global Endocrine Disruption Screening Historic Market Size by Type (2020-2025)
4.2 Global Endocrine Disruption Screening Forecasted Market Size by Type (2026-2031)
5 Endocrine Disruption Screening Breakdown Data by Application
5.1 Global Endocrine Disruption Screening Historic Market Size by Application (2020-2025)
5.2 Global Endocrine Disruption Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Endocrine Disruption Screening Market Size (2020-2031)
6.2 North America Endocrine Disruption Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Endocrine Disruption Screening Market Size by Country (2020-2025)
6.4 North America Endocrine Disruption Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocrine Disruption Screening Market Size (2020-2031)
7.2 Europe Endocrine Disruption Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Endocrine Disruption Screening Market Size by Country (2020-2025)
7.4 Europe Endocrine Disruption Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Disruption Screening Market Size (2020-2031)
8.2 Asia-Pacific Endocrine Disruption Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Endocrine Disruption Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Endocrine Disruption Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endocrine Disruption Screening Market Size (2020-2031)
9.2 Latin America Endocrine Disruption Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Endocrine Disruption Screening Market Size by Country (2020-2025)
9.4 Latin America Endocrine Disruption Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Disruption Screening Market Size (2020-2031)
10.2 Middle East & Africa Endocrine Disruption Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Endocrine Disruption Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Endocrine Disruption Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Bioarray
11.1.1 Creative Bioarray Company Details
11.1.2 Creative Bioarray Business Overview
11.1.3 Creative Bioarray Endocrine Disruption Screening Introduction
11.1.4 Creative Bioarray Revenue in Endocrine Disruption Screening Business (2020-2025)
11.1.5 Creative Bioarray Recent Development
11.2 Xenometrix AG
11.2.1 Xenometrix AG Company Details
11.2.2 Xenometrix AG Business Overview
11.2.3 Xenometrix AG Endocrine Disruption Screening Introduction
11.2.4 Xenometrix AG Revenue in Endocrine Disruption Screening Business (2020-2025)
11.2.5 Xenometrix AG Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Endocrine Disruption Screening Introduction
11.3.4 Charles River Laboratories Revenue in Endocrine Disruption Screening Business (2020-2025)
11.3.5 Charles River Laboratories Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Endocrine Disruption Screening Introduction
11.4.4 Eurofins Scientific Revenue in Endocrine Disruption Screening Business (2020-2025)
11.4.5 Eurofins Scientific Recent Development
11.5 Smithers
11.5.1 Smithers Company Details
11.5.2 Smithers Business Overview
11.5.3 Smithers Endocrine Disruption Screening Introduction
11.5.4 Smithers Revenue in Endocrine Disruption Screening Business (2020-2025)
11.5.5 Smithers Recent Development
11.6 SGS SA
11.6.1 SGS SA Company Details
11.6.2 SGS SA Business Overview
11.6.3 SGS SA Endocrine Disruption Screening Introduction
11.6.4 SGS SA Revenue in Endocrine Disruption Screening Business (2020-2025)
11.6.5 SGS SA Recent Development
11.7 JRF Global
11.7.1 JRF Global Company Details
11.7.2 JRF Global Business Overview
11.7.3 JRF Global Endocrine Disruption Screening Introduction
11.7.4 JRF Global Revenue in Endocrine Disruption Screening Business (2020-2025)
11.7.5 JRF Global Recent Development
11.8 Mérieux NutriSciences
11.8.1 Mérieux NutriSciences Company Details
11.8.2 Mérieux NutriSciences Business Overview
11.8.3 Mérieux NutriSciences Endocrine Disruption Screening Introduction
11.8.4 Mérieux NutriSciences Revenue in Endocrine Disruption Screening Business (2020-2025)
11.8.5 Mérieux NutriSciences Recent Development
11.9 Alpha Analytical
11.9.1 Alpha Analytical Company Details
11.9.2 Alpha Analytical Business Overview
11.9.3 Alpha Analytical Endocrine Disruption Screening Introduction
11.9.4 Alpha Analytical Revenue in Endocrine Disruption Screening Business (2020-2025)
11.9.5 Alpha Analytical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Endocrine Disruption Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of In Vitro Screening
Table 3. Key Players of In Vivo Screening
Table 4. Global Endocrine Disruption Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Endocrine Disruption Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Endocrine Disruption Screening Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Endocrine Disruption Screening Market Share by Region (2020-2025)
Table 8. Global Endocrine Disruption Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Endocrine Disruption Screening Market Share by Region (2026-2031)
Table 10. Endocrine Disruption Screening Market Trends
Table 11. Endocrine Disruption Screening Market Drivers
Table 12. Endocrine Disruption Screening Market Challenges
Table 13. Endocrine Disruption Screening Market Restraints
Table 14. Global Endocrine Disruption Screening Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Endocrine Disruption Screening Market Share by Players (2020-2025)
Table 16. Global Top Endocrine Disruption Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Disruption Screening as of 2024)
Table 17. Ranking of Global Top Endocrine Disruption Screening Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Endocrine Disruption Screening Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Endocrine Disruption Screening, Headquarters and Area Served
Table 20. Global Key Players of Endocrine Disruption Screening, Product and Application
Table 21. Global Key Players of Endocrine Disruption Screening, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Endocrine Disruption Screening Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Endocrine Disruption Screening Revenue Market Share by Type (2020-2025)
Table 25. Global Endocrine Disruption Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Endocrine Disruption Screening Revenue Market Share by Type (2026-2031)
Table 27. Global Endocrine Disruption Screening Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Endocrine Disruption Screening Revenue Market Share by Application (2020-2025)
Table 29. Global Endocrine Disruption Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Endocrine Disruption Screening Revenue Market Share by Application (2026-2031)
Table 31. North America Endocrine Disruption Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Endocrine Disruption Screening Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Endocrine Disruption Screening Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Endocrine Disruption Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Endocrine Disruption Screening Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Endocrine Disruption Screening Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Endocrine Disruption Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Endocrine Disruption Screening Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Endocrine Disruption Screening Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Endocrine Disruption Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Endocrine Disruption Screening Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Endocrine Disruption Screening Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Endocrine Disruption Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Endocrine Disruption Screening Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Endocrine Disruption Screening Market Size by Country (2026-2031) & (US$ Million)
Table 46. Creative Bioarray Company Details
Table 47. Creative Bioarray Business Overview
Table 48. Creative Bioarray Endocrine Disruption Screening Product
Table 49. Creative Bioarray Revenue in Endocrine Disruption Screening Business (2020-2025) & (US$ Million)
Table 50. Creative Bioarray Recent Development
Table 51. Xenometrix AG Company Details
Table 52. Xenometrix AG Business Overview
Table 53. Xenometrix AG Endocrine Disruption Screening Product
Table 54. Xenometrix AG Revenue in Endocrine Disruption Screening Business (2020-2025) & (US$ Million)
Table 55. Xenometrix AG Recent Development
Table 56. Charles River Laboratories Company Details
Table 57. Charles River Laboratories Business Overview
Table 58. Charles River Laboratories Endocrine Disruption Screening Product
Table 59. Charles River Laboratories Revenue in Endocrine Disruption Screening Business (2020-2025) & (US$ Million)
Table 60. Charles River Laboratories Recent Development
Table 61. Eurofins Scientific Company Details
Table 62. Eurofins Scientific Business Overview
Table 63. Eurofins Scientific Endocrine Disruption Screening Product
Table 64. Eurofins Scientific Revenue in Endocrine Disruption Screening Business (2020-2025) & (US$ Million)
Table 65. Eurofins Scientific Recent Development
Table 66. Smithers Company Details
Table 67. Smithers Business Overview
Table 68. Smithers Endocrine Disruption Screening Product
Table 69. Smithers Revenue in Endocrine Disruption Screening Business (2020-2025) & (US$ Million)
Table 70. Smithers Recent Development
Table 71. SGS SA Company Details
Table 72. SGS SA Business Overview
Table 73. SGS SA Endocrine Disruption Screening Product
Table 74. SGS SA Revenue in Endocrine Disruption Screening Business (2020-2025) & (US$ Million)
Table 75. SGS SA Recent Development
Table 76. JRF Global Company Details
Table 77. JRF Global Business Overview
Table 78. JRF Global Endocrine Disruption Screening Product
Table 79. JRF Global Revenue in Endocrine Disruption Screening Business (2020-2025) & (US$ Million)
Table 80. JRF Global Recent Development
Table 81. Mérieux NutriSciences Company Details
Table 82. Mérieux NutriSciences Business Overview
Table 83. Mérieux NutriSciences Endocrine Disruption Screening Product
Table 84. Mérieux NutriSciences Revenue in Endocrine Disruption Screening Business (2020-2025) & (US$ Million)
Table 85. Mérieux NutriSciences Recent Development
Table 86. Alpha Analytical Company Details
Table 87. Alpha Analytical Business Overview
Table 88. Alpha Analytical Endocrine Disruption Screening Product
Table 89. Alpha Analytical Revenue in Endocrine Disruption Screening Business (2020-2025) & (US$ Million)
Table 90. Alpha Analytical Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report


List of Figures
Figure 1. Endocrine Disruption Screening Picture
Figure 2. Global Endocrine Disruption Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Endocrine Disruption Screening Market Share by Type: 2024 VS 2031
Figure 4. In Vitro Screening Features
Figure 5. In Vivo Screening Features
Figure 6. Global Endocrine Disruption Screening Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Endocrine Disruption Screening Market Share by Application: 2024 VS 2031
Figure 8. Agricultural Case Studies
Figure 9. Medical Case Studies
Figure 10. Environmental Case Studies
Figure 11. Endocrine Disruption Screening Report Years Considered
Figure 12. Global Endocrine Disruption Screening Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Endocrine Disruption Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Endocrine Disruption Screening Market Share by Region: 2024 VS 2031
Figure 15. Global Endocrine Disruption Screening Market Share by Players in 2024
Figure 16. Global Top Endocrine Disruption Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Disruption Screening as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Endocrine Disruption Screening Revenue in 2024
Figure 18. North America Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Endocrine Disruption Screening Market Share by Country (2020-2031)
Figure 20. United States Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Endocrine Disruption Screening Market Share by Country (2020-2031)
Figure 24. Germany Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Endocrine Disruption Screening Market Share by Region (2020-2031)
Figure 32. China Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Endocrine Disruption Screening Market Share by Country (2020-2031)
Figure 40. Mexico Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Endocrine Disruption Screening Market Share by Country (2020-2031)
Figure 44. Turkey Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Endocrine Disruption Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Creative Bioarray Revenue Growth Rate in Endocrine Disruption Screening Business (2020-2025)
Figure 48. Xenometrix AG Revenue Growth Rate in Endocrine Disruption Screening Business (2020-2025)
Figure 49. Charles River Laboratories Revenue Growth Rate in Endocrine Disruption Screening Business (2020-2025)
Figure 50. Eurofins Scientific Revenue Growth Rate in Endocrine Disruption Screening Business (2020-2025)
Figure 51. Smithers Revenue Growth Rate in Endocrine Disruption Screening Business (2020-2025)
Figure 52. SGS SA Revenue Growth Rate in Endocrine Disruption Screening Business (2020-2025)
Figure 53. JRF Global Revenue Growth Rate in Endocrine Disruption Screening Business (2020-2025)
Figure 54. Mérieux NutriSciences Revenue Growth Rate in Endocrine Disruption Screening Business (2020-2025)
Figure 55. Alpha Analytical Revenue Growth Rate in Endocrine Disruption Screening Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies